ALKS has been in the news 563% more than usual
Nov 14, 2025, 1:31 PM
-8.14%
What does ALKS do
Alkermes Plc is a biopharmaceutical company based in Dublin, focused on developing treatments for alcohol and opioid dependence, schizophrenia, and bipolar I disorder, employing 2,100 people. Its key products include LYBALVI, ARISTADA, and VIVITROL, with ongoing development for neurological disorders and cancer.
ALKS has been in the news recently: ALKERMES PLC reported a 15% increase in revenue for the quarter, reflecting strong growth in its core products and an expanding customer base. The company is currently evaluating its options in response to Avadel's announcement of a potential acquisition offer from Lundbeck, while remaining compliant with their existing Transaction Agreement.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.